| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/21/2001 | EP1083879A1 Methods and devices for providing prolonged drug therapy |
| 03/21/2001 | EP1083870A1 Dentifrice composition containing encapsulated reactive ingredients |
| 03/21/2001 | EP1083861A1 Hydrous cosmetic or pharmaceutical sticks |
| 03/21/2001 | EP0833662B1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 03/21/2001 | EP0717616B1 Process for conditioning substances |
| 03/21/2001 | CN2423892Y Isolating medicinal capsule |
| 03/21/2001 | CN1288388A Stabilization of lipid DNA formulations during nebulization |
| 03/21/2001 | CN1288387A Sustained release compositions, process for producing the same and utilization thereof |
| 03/21/2001 | CN1288386A Disintegrating agent |
| 03/21/2001 | CN1288385A Pharmaceutical formulations and processes for their prepn. |
| 03/21/2001 | CN1288380A Utilization of powder prepns. contg. hydroxypyridones treating LEG ulcer and decubitus ulcers |
| 03/21/2001 | CN1288379A Method and kits for treating vulvovaginal candidiasis with micronazole nitrate |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288376A Transdermal therapeutic system (TTS) contg. oxybutynin |
| 03/21/2001 | CN1288375A TTS contg. an antioxidant |
| 03/21/2001 | CN1288374A Method for producing sustained-release prepn. |
| 03/21/2001 | CN1288373A Prepn. of a lipid blend and a phospholipid suspension contg. the lipid blend, and contrast agents based on these |
| 03/21/2001 | CN1288372A Fluorometholone suspension eye drops |
| 03/21/2001 | CN1288371A Lipoprotein creams |
| 03/21/2001 | CN1288368A Container for an inhalation anesthetic |
| 03/21/2001 | CN1287877A Micro-capsule and its prepn. method |
| 03/21/2001 | CN1287857A Traditional Chinese patented medicine for treating hepatitis and its prepn. method |
| 03/21/2001 | CN1287850A Prescription of external use paste made of Chinese herb medicine for treating vascular headache |
| 03/21/2001 | CN1287836A Doukey-hide gelatin capsule |
| 03/21/2001 | CN1287834A Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 |
| 03/21/2001 | CN1287830A Forming medicine pills in water contg. active compound melt material |
| 03/21/2001 | CN1063340C Glycosuria lowering capasule contg. pearl and Radix astragali and its prodn. method |
| 03/21/2001 | CN1063336C Tincture for treatment of toothache |
| 03/21/2001 | CN1063335C Chinese medicine preparation for reducing fat and dilating coronary artery |
| 03/21/2001 | CN1063334C Nutrition liquor contg. silk moth essence |
| 03/21/2001 | CN1063327C Application for RNA enzyme inhibition factor used as tumour inhibitor |
| 03/21/2001 | CN1063322C Aqueous liquid composition for eye external use as eyedrops |
| 03/21/2001 | CN1063321C Medicaments aerosol prepn. and preparing method therefor and releasing apparatus therefor |
| 03/20/2001 | US6204308 Microencapsulating an active agent wherein a water-in-oil emulsion, containing a matrix-forming polymer and an active agent, is dispersed in an aqueous external phase to form a microencapsulated product; especially polyethylene carbonate |
| 03/20/2001 | US6204299 Foaming agents used to prepare closed cell polyurethane foams |
| 03/20/2001 | US6204296 Patient oxygenation using stabilized fluorocarbon emulsions |
| 03/20/2001 | US6204270 Anti-tnf-alpha agent and a mucoadhesive delivery system, wherein the anti-tnf-alpha agent comprises a tnf-alpha neutralizing agent. |
| 03/20/2001 | US6204258 Enhancing hair growth or treating alopecia in a subject uses topically administered estrogen receptor antagonists. |
| 03/20/2001 | US6204255 Molar ratio of sodium valproate to cyclodextrin within the range of from 1:0.01 to 1:0.09. |
| 03/20/2001 | US6204254 Biocompatible surfaces and a method for their preparation |
| 03/20/2001 | US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 03/20/2001 | US6204243 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204036 Stable, freeze dried mixture; parenteral administering |
| 03/20/2001 | US6204033 Preparation of polyvinyl alcohol-based magnetic particles for binding biomolecules |
| 03/20/2001 | US6203817 Reduction of skin reactions caused by transdermal drug delivery |
| 03/20/2001 | US6203813 Opiate antagonist, steroidal antiinflammatory agent and carrier; sustained release; drug abuse treatment |
| 03/20/2001 | US6203812 Polyurethane/poly(n-vinyl lactam) blend with microbiocide; easily removed |
| 03/20/2001 | US6203802 Composition for the cosmetic and/or pharmaceutical treatment of the upper layers of the epidermis by topical application to the skin, and corresponding preparation process |
| 03/20/2001 | US6203796 Oregano-based therapeutic composition |
| 03/20/2001 | CA2193481C Colonic drug delivery composition |
| 03/20/2001 | CA2089003C Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018055A1 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017580A2 Fluid delivery device with temperature controlled energy source |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017567A2 Improved container composition for diagnostic agents |
| 03/15/2001 | WO2001017556A1 Vaccine preparations for mucosal administration |
| 03/15/2001 | WO2001017549A1 Stably storable oxygen transfusion |
| 03/15/2001 | WO2001017546A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 03/15/2001 | WO2001017541A1 Composition for extending post meal satiety |
| 03/15/2001 | WO2001017536A2 Novel autogenous vaccines used to obtain an immune tolerance |
| 03/15/2001 | WO2001017527A1 Preventive and therapeutic agents for eye diseases |
| 03/15/2001 | WO2001017525A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 03/15/2001 | WO2001017523A1 Compositions and methods for modification of skin lipid content |
| 03/15/2001 | WO2001017511A1 Method of intracellular sustained-release of drug and preparations |
| 03/15/2001 | WO2001017510A1 Agent for stimulating bowel function and method for producing the same |
| 03/15/2001 | WO2001017509A1 Method for improving and maintaining bowel function as well as a method for the production thereof |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017506A1 Proteinic drug delivery system using membrane mimetics |
| 03/15/2001 | WO2001017505A1 Medicinal compositions for oral use |
| 03/15/2001 | WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 03/15/2001 | WO2001017503A2 Sugar compositions |
| 03/15/2001 | WO2001017480A2 Methods and compositions for preventing and treating urinary tract disorders |
| 03/15/2001 | WO2001017479A2 Methods and compositions for preventing and treating prostate disorders |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2001017377A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 03/15/2001 | WO2000078353A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 03/15/2001 | WO2000071125A3 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction |
| 03/15/2001 | WO2000064684A3 Method and device for labeling a two-dimensional polymer adhesive system, especially a transdermal therapeutic system |
| 03/15/2001 | WO2000064418A3 Transdermal therapeutic system with neutralized acrylic adhesive patch |
| 03/15/2001 | WO2000059469A3 Endodontic fibers and methods of use therefor |
| 03/15/2001 | WO2000057854A3 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | WO2000010562A8 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same |
| 03/15/2001 | US20010000036 Micronized dyes, drugs, carotenoids, etc. formed by dissolving in a fluid gas, e.g. carbon dioxide, nitrogen, and the loaded fluid gas dissolved in water or a solvent; then decompression; protective bubbles; antiagglomerants |
| 03/15/2001 | US20010000029 A stable gel composition comprising a polyacrylic acid compound, a polyvalent metal component and 75-95 % weight of water user for a covering or laminated sheet to cool bodies to induce sleep |
| 03/15/2001 | DE19943553A1 Balsam for care and treatment of damaged skin, e.g. with wounds or ulcers, comprising carrier, e.g. St. John's wort oil, and herbal active agents, e.g. lavender, geranium and bergamot essences |
| 03/15/2001 | DE19943501A1 Unterwassergranulation wirkstoffhaltiger Schmelzen Underwater granulation medicated melting |
| 03/15/2001 | DE19943491A1 Verbesserte Komprimate Improved compressed |
| 03/15/2001 | DE19943317C1 Kunststofffolien, insbesondere für die Verwendung in einem dermalen oder transdermalen therapeutischen System und Verfahren zu ihrer Herstellung Plastic films, in particular for use in a dermal or transdermal therapeutic system and method for their preparation |
| 03/15/2001 | DE19942365A1 Bulking agent based on three dimensional polymer network useful in stimulation of bowel activity and normalization of bowel evacuation |
| 03/15/2001 | DE19942283A1 Apparatus for producing stable, concentrated liquid preparation containing gaseous or volatile anesthetic, e.g. xenon, including premixing and fine mixing or homogenization stages |
| 03/15/2001 | DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 03/15/2001 | DE10044420A1 Tissue-compatible composite for prolonged, controlled drug release, comprising drug-impregnated composite obtained by bonding two ceramic bodies, preferably used as bone substitute |
| 03/15/2001 | CA2671852A1 Delivery device |